Is valproic acid approved as a sole therapy for absence seizures?
Valproic acid is an anti-epileptic drug approved by the FDA to treat absence seizures on its own. This approval applies to both simple absence seizures, which involve brief clouding of consciousness, and complex absence seizures, which include other clinical signs. The drug is indicated for use as monotherapy in these conditions.
What the research says
FDA approvals for valproic acid capsules and oral solutions explicitly list them as indicated for sole and adjunctive therapy of simple and complex absence seizures 12. This means the medication is cleared for use as the only treatment for these specific seizure types. The approval covers different formulations, including sprinkle capsules and oral solutions, confirming the drug's role as a primary treatment option 5.
What to ask your doctor
- Is valproic acid the right choice for my specific type of absence seizure?
- What are the potential side effects of using valproic acid as my only seizure medication?
- Are there any risks to me or my unborn child if I take valproic acid while pregnant or planning pregnancy?
- How will we monitor my liver health while I take this medication?
This question is drawn from common patient questions about Neurology and answered using cited medical research. We do not provide individualized advice.